mbiomics GmbH
Christopher Weidenmaier is a Chief Scientific Officer at mbiomics GmbH and was previously the Director of Research and Head of Host Cell Biology/Immunology at Finch Therapeutics Group. With a strong background in microbiome therapeutics, Christopher has also worked as an Assoc Director of Host Cell Biology and a Principal Investigator at the Hospital of the University of Tübingen. Christopher has a PhD in Biology and has conducted research on the role of cell wall teichoic acids in bacterial infections.
This person is not in any offices
mbiomics GmbH
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.